Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy - Related Studies

Validation Study of RA-INF-Dx, a Multigene Molecular Test Used to Predict Non-Response to INfliximab Therapy (PRINT)

This study has been terminated.

( Recruitment difficulties )

Study NCT01299545 Information provided by TcLand Expression S.A.

First Received on February 16, 2011. Last Updated on January 31, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Rheumatoid Arthritis

Additional conditions recognized in this trial

Arthritis
Arthritis, Rheumatoid

More general conditions related to this trial

Additional drug interventions recognized in this trial

Infliximab
Methotrexate

More general drug interventions related to this trial

Sponsors listed in this trial